Descriptive statistics of outcomes at baseline, post-intervention, and follow-up and estimates of the linear mixed effects model for the outcomes. حسب Ana Beato (20489933)

Unit root test. حسب Fuwei Wang (721008)

الموضوعات:

Sample inspection results of threshold effect. حسب Fuwei Wang (721008)

الموضوعات:

Regression results with one control variable removed one by one. حسب Fuwei Wang (721008)

الموضوعات:

Regression estimation results of panel threshold model. حسب Fuwei Wang (721008)

الموضوعات:

Theoretical analysis framework. حسب Fuwei Wang (721008)

الموضوعات:

Regression results of poverty level expressed by poverty population. حسب Fuwei Wang (721008)

الموضوعات:

Estimation results of panel threshold model parameters with core explanatory variables lagging behind one period. حسب Fuwei Wang (721008)

الموضوعات:

Descriptive statistical analysis of variables. حسب Fuwei Wang (721008)

الموضوعات:

Results of the self-sampling test on threshold effect of core explanatory variables lagging behind one period. حسب Fuwei Wang (721008)

الموضوعات:

The core explanatory variable is the threshold effect of the number of poor people. حسب Fuwei Wang (721008)

الموضوعات:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... حسب Naoya Itoh (6029276)